# Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa

> **NCT01533077** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 18 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** BIA 9-1067
- **DRUG:** Sinemet® 100/25 mg

## Key facts

- **NCT ID:** NCT01533077
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-10
- **Final completion:** 2010-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533077, "Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01533077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*